Eosinophilic Esophagitis
Gitit Tomer
<p><span><span>Dr. Tomer is the director of the Pediatric Inflammatory Bowel Disease program at the Children's Hospital at Montefiore. </span></span>She is Associate Professor of Clinical Pediatrics. Dr. Tomer graduated from Sackler School of Medicine, Tel- Aviv, Israel. Dr. Tomer completed her Pediatric Residency at New York University School of Medicine and her Pediatric Gastroenterogy and Nutrition Fellowship at Mount Sinai Medical Center, New York. Dr Tomer was Assistant Professor of Pediatrics in the Division of Pediatric Gastroenterology at Cincinnati Children’s Hospital for four years prior to joining the Pediatric GI Division at The Children’s Hospital at Montefiore in 2009. Dr. Tomer’s research interests include inflammatory bowel diseases, quality improvement work, and capsule endoscopy. </p>
<p>1. Obtaining research biopsies during pediatric colonoscopy: Safety and adverse events. Mait-Kaufman J, Kahn S, Tomer G. World J Gastrointest Endosc. 2015 Jun 25;7(7):736-40. doi: 10.4253/wjge.v7.i7.736.</p>
<p>2. Improving Nonattendance at Outpatient Pediatric Endoscopy Unit of a Tertiary Center. Kogan-Liberman D, Rivas Y, Thompson J, Tomer G. J Pediatr Gastroenterol Nutr. 2015 Aug;61(2):234-7. doi: 10.1097/MPG.0000000000000791.</p>
<p>3. Improving the timeliness of procedures in a pediatric endoscopy suite. Tomer G, Choi S, Montalvo A, Sutton S, Thompson J, Rivas Y. Pediatrics. 2014 Feb;133(2):e428-33. doi: 10.1542/peds.2013-2316. Epub 2014 Jan 20.</p>
<p>4. Improved outcomes with quality improvement interventions in pediatric inflammatory bowel disease. Samson CM, Morgan P, Williams E, Beck L, Addie-Carson R, McIntire S, Booth A, Mendez E, Luzader C, Tomer G, Saeed S, Donovan E, Bucuvalas J, Denson LA. J Pediatr Gastroenterol Nutr. 2012 Dec;55(6):679-88. doi: 10.1097/MPG.0b013e318262de16.</p>
<p>5.Factors that determine risk for surgery in pediatric patients with Crohn's disease. Schaefer ME, Machan JT, Kawatu D, Langton CR, Markowitz J, Crandall W, Mack DR, Evans JS, Pfefferkorn MD, Griffiths AM, Otley AR, Bousvaros A, Kugathasan S, Rosh JR, Keljo DJ, Carvalho RS, Tomer G, Mamula P, Kay MH, Kerzner B, Oliva-Hemker M, Kappelman MD, Saeed SA, Hyams JS, Leleiko NS. Clin Gastroenterol Hepatol. 2010 Sep;8(9):789-94. doi: 10.1016/j.cgh.2010.05.021. Epub 2010 May 31.</p>
<p> 6. Extraintestinal manifestations of pediatric inflammatory bowel disease and their relation to disease type and severity. Dotson JL, Hyams JS, Markowitz J, LeLeiko NS, Mack DR, Evans JS, Pfefferkorn MD, Griffiths AM, Otley AR, Bousvaros A, Kugathasan S, Rosh JR, Keljo D, Carvalho RS, Tomer G, Mamula P, Kay MH, Kerzner B, Oliva-Hemker M, Langton CR, Crandall W. J Pediatr Gastroenterol Nutr. 2010 Aug;51(2):140-5. doi: 10.1097/MPG.0b013e3181ca4db4.</p>
<p>7. Outcome following infliximab therapy in children with ulcerative colitis. Hyams JS, Lerer T, Griffiths A, Pfefferkorn M, Stephens M, Evans J, Otley A, Carvalho R, Mack D, Bousvaros A, Rosh J, Grossman A, Tomer G, Kay M, Crandall W, Oliva-Hemker M, Keljo D, LeLeiko N, Markowitz J; Pediatric Inflammatory Bowel Disease Collaborative Research Group. Am J Gastroenterol. 2010 Jun;105(6):1430-6. doi: 10.1038/ajg.2009.759. Epub 2010 Jan 26.</p>
<p> 8. Polymorphisms in the IBD5 locus are associated with Crohn disease in pediatric Ashkenazi Jewish patients. Tomer G, Wetzler G, Keddache M, Denson LA. J Pediatr Gastroenterol Nutr. 2009 May;48(5):531-7. doi: 10.1097/MPG.0b013e318183138a.</p>
<p>9. Granulocyte-macrophage colony-stimulating factor autoantibodies in murine ileitis and progressive ileal Crohn's disease. Han X, Uchida K, Jurickova I, Koch D, Willson T, Samson C, Bonkowski E, Trauernicht A, Kim MO,Tomer G, Dubinsky M, Plevy S, Kugathsan S, Trapnell BC, Denson LA. Gastroenterology. 2009 Apr;136(4):1261-71, e1-3. doi: 10.1053/j.gastro.2008.12.046. Epub 2008 Dec 24.</p>
<p>10. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Kugathasan S, Baldassano RN, Bradfield JP, Sleiman PM, Imielinski M, Guthery SL, Cucchiara S, Kim CE, Frackelton EC, Annaiah K, Glessner JT, Santa E, Willson T, Eckert AW, Bonkowski E, Shaner JL, Smith RM, Otieno FG, Peterson N, Abrams DJ, Chiavacci RM, Grundmeier R, Mamula P,Tomer G, Piccoli DA, Monos DS, Annese V, Denson LA, Grant SF, Hakonarson H. Nat Genet. 2008 Oct;40(10):1211-5. doi: 10.1038/ng.203. Epub 2008 Aug 31.</p>
<p> 11. Genetic variants in the autophagy pathway contribute to paediatric Crohn's disease. Peterson N, Guthery S, Denson L, Lee J, Saeed S, Prahalad S, Biank V, Ehlert R, Tomer G, Grand R, Rudolph C, Kugathasan S. Gut. 2008 Sep;57(9):1336-7; author reply 1337. doi: 10.1136/gut.2008.152207. No abstract available.</p>
<p> 12. Electronic clinical challenges and images in GI. Meckel's diverticulum. Zeisler B, Moyer SM, Farrell M, Collins MH, Tomer G. Gastroenterology. 2008 Apr;134(4):e3-4. doi: 10.1053/j.gastro.2008.02.039. No abstract available. Erratum in: Gastroenterology. 2008 Jul;135(1):326.</p>
<p>13.NOD2/CARD15 variants are associated with lower weight at diagnosis in children with Crohn's disease. Tomer G, Ceballos C, Concepcion E, Benkov KJ. Am J Gastroenterol. 2003 Nov;98(11):2479-84.</p>
<p>14. Disorders of bile formation and biliary transport. Tomer G, Shneider BL. Gastroenterol Clin North Am. 2003 Sep;32(3):839-55, vi. Review.</p>
<p>15. Differential developmental regulation of rat liver canalicular membrane transporters Bsep and Mrp2. Tomer G, Ananthanarayanan M, Weymann A, Balasubramanian N, Suchy FJ. Pediatr Res. 2003 Feb;53(2):288-94.</p>
<p> </p>
<p> </p>
<p>Gitit Tomer, MD, is Director of the Pediatric Inflammatory Bowel Disease (IBD) Program at Children’s Hospital at Montefiore (CHAM) and Professor of Pediatrics at our Albert Einstein College of Medicine. Dr. Tomer has been a member of the Montefiore team since 2009, with a clinical focus on inflammatory bowel disease, performance improvement and capsule endoscopy.</p><p>Dr. Tomer received her medical degree from Sackler School of Medicine, Tel-Aviv University, in 1995. She completed her Pediatric internship and residency at New York University School of Medicine in 1998, and went on to complete her Pediatric Gastroenterology and Nutrition fellowship at Mount Sinai Medical Center in 2001.</p><p>Dr. Tomer’s focus on IBD, performance improvement and endoscopy extend to her research interests. She is the CHAM physician leader of ImproveCareNow, a national collaborative that champions improved care for children and youth with Crohn’s disease and ulcerative colitis. Her research in pediatric IBD examines many facets, extending from the racial differences in initial presentation, early treatment and 1-year outcomes in pediatric Crohn’s disease, to differences in satisfaction with work-life balance among pediatric gastroenterologists. Dr. Tomer’s work has been published in a number of reviewed journals, books, review articles, and abstracts.</p><p>Dr. Tomer is board certified by the American Board of Pediatrics in Pediatric Gastroenterology. She is a member of the American Gastroenterological Association (AGA) and the Crohn's & Colitis Foundation of America (CCFA), and serves as the chair of the Professional Development Committee of the North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN).</p>
Aaron Zev Tokayer
<p>Dr. Tokayer received his B.A. in from Yeshiva College and his M.D. from Albert Einstein College of Medicine of Yeshiva University. He completed an internship and residency at the Bronx Municipal Hospital Center and GI and Hepatology fellowship at Johns Hopkins Medical Center. He received an MHS degree in Clinical Epidemiology from Johns Hopkins School of Public Health. Dr. Tokayer then joined the Montefiore GI Faculty in 1992. He has been involved in the spectrum of clinical patient care, endoscopic interventions and teaching in the GI fellowship program. His areas of interest include clinical practice, patient care and education, endoscopic procedures and interventions, functional GI and motility disorders. He is Director of the GI Motility Lab where studies such as Esophageal Manometry, Esophageal Acid Monitoring and Impedance Testing, Ano-rectal Manometry and Defecatory Testing, Hydrogen Breath Testing for Bacterial overgrowth and Carbohydrate Maldigestion , and studies of gastric and intestinal transit. He works closely with colleagues of the Department of Radiology and Nuclear Medicine as well as the Department of Surgery in diagnosing and treating GI motility disorders.</p>
John F. Thompson
<!--Dr. Thompson completed his Pediatric Residency at the University of Chicago School of Medicine and his Pediatric Gastroenterology and Nutrition Fellowship at Babies Hospital/Columbia University. He was the Director of Pediatric Gastroenterology and Nutrition at the University of Miami Miller School of Medicine for 16 years prior to assuming the position of Chief of Pediatric Gastroenterology at The Children?s Hospital at Montefiore. He has earned an international reputation as a leader in the treatment of a full range of complex childhood gastrointestinal and liver conditions including Crohn?s disease, ulcerative colitis, celiac disease, short bowel syndrome, chronic abdominal pain and intestinal transplantation.--><p>John F. Thompson, MD, is Chief, Division of Pediatric Gastroenterology, Hepatology and Nutrition at Children's Hospital at Montefiore (CHAM) and Professor of Pediatrics at our Albert Einstein College of Medicine. Dr. Thompson specializes in short bowel syndrome, Crohn's disease, ulcerative colitis, celiac disease, eosinophilic esophagitis, feeding disorder, and chronic abdominal pain. </p><p>Dr. Thompson graduated from the College of the Holy Cross with a B.A. and M.S. in Chemistry. He was awarded his Doctor of Medicine from Loyola University Stritch School of Medicine in 1977. He completed a residency in Pediatrics at Wyler's Children's Hospital, University of Chicago Hospitals and Clinics in 1980, followed by a fellowship in Pediatric Gastroenterology and Nutrition at Babies Hospital, Columbia University Medical Center. Dr. Thompson was Chief of the Division of Pediatric Gastroenterology and Nutrition in the University of Miami Miller School of Medicine for 15 years before he was recruited to CHAM in 2009.</p><p>Under Dr. Thompson's leadership, the Division of Pediatric Gastroenterology, Hepatology and Nutrition at CHAM has shown remarkable growth and is now one of the premier programs in the country with expertise in inflammatory bowel disease, hepatology and liver transplantation, therapeutic endoscopy, intestinal failure, celiac disease, aerodigestive and eosinophilic gastrointestinal disorders. </p><p>Dr. Thompson is the director of the Intestinal Rehabilitation Program at CHAM. His research focuses on ways to improve the lives and outcomes of children who have intestinal failure and short bowel syndrome, with multiple active Institutional Review Board (IRB)-approved studies. He also is the Principal Investigator in two multicentered international clinical trials examining the effectiveness of teduglutide for the treatment of short bowel syndrome in children</p>
Jonathan M. Schwartz
<p>Jonathan M. Schwartz is a board Certified Transplant Hepatologist. He is a graduate of Tel Aviv University, Sackler School of Medicine. He was an Internal Medicine Resident at Albert Einstein College of Medicine and a Fellow in Gastroenterology/Transplant Hepatology at the University of Washington in Seattle. He returned to New York in 2011 from Portland, Oregon where he served as an Associate Professor of Medicine at Oregon Health and Sciences University.</p>
<p>Dr. Schwartz has an interest in treating patients with acute and chronic liver diseases including those patients with advanced liver diseases who require liver transplantation.</p>
<p>He has a special interest in the multidisciplinary care of patients with liver tumors.</p>
<p><strong><br /></strong></p>
<ul>
<li>Estes JD, Stolpman D, Olyaei A, Ham JM, <strong>Schwartz JM</strong>, Orloff SL. High Prevalence of Potentially Hepatotoxic Herbal Supplement Use in Fulminant Hepatic Failure Patients. Arch Surg. 2003;138(8):852-8.</li>
<li><strong>Schwartz JM</strong>, Beymer C, Althaus SJ, Larson AM, Zaman A, Glickerman D, Kowdley KV. Cardiopulmonary Consequences of Transjugular Intrahepatic Portosystemic Shunts: Role of Increased Pulmonary Artery Pressure. J Clin Gastroenterol 2004;38(7):590-594.</li>
<li>Lim LL, Scarborough J, Thorne J, Graham E, Kempen J, Mackensen F, Nguyen Q D, Prabriputaloong T, Read R, Suhler EB, <strong>Schwartz JM</strong>, Smith JR. Uveitis in Patients with Autoimmune Hepatitis. Am J Ophthalmol. 2009;147(2):332-338.</li>
<li>O’Glasser AY, Scott DA, Corless CL, Zaman A, Sasaki A, Gopal DV, Rayhill SC, Orloff SL, Ham JM, Rabkin JM, Flora K, Davies CH, Broberg CS, and <strong>Schwartz JM.</strong>Hepatic and Cardiac Iron Overload Among Patients with End-Stage Liver Disease Referred for Liver Transplantation. Clinical Transplantation. Clin Transplant. 2010 Sep-Oct;24(5):643-51.</li>
<li>Kanwal F, Befeler A, Chari R, Marrero J, Kahn J, Afdhal N, Morgan T, Roberts L, Mohanty SR, <strong>Schwartz J</strong>, Van Thiel D, Hassanein TI, Li J, Zeringue A, DiBisceglie A. Rate of Potentially Curative Treatment in Patients with Hepatocellular Carcinoma. Aliment Pharmacol Ther. 2012 Aug;36(3):257-65.</li>
<li>Bichoupan K1, <strong>Schwartz JM,</strong> Martel-Laferriere V, Giannattasio ER, Marfo K, Odin JA, Liu LU, Schiano TD, Perumalswami P, Bansal M, Gaglio PJ, Kalia H,Dieterich DT, Branch AD, Reinus JF. Effect of Fibrosis on Adverse Events in Patients with Hepatitis C Treated with Telaprevir. Aliment Pharmacol Ther. 2014;39(2):209-16.</li>
<li><strong>Schwartz J</strong> and Carithers RL. Epidemiology and Etiologic Associations of Primary Hepatocellular Carcinoma. In Rose BD, editor. Up to date in Gastroenterology and Hepatology. Up to date, Inc. Wellesley, MA, Updated 2014.</li>
<li><strong>Schwartz JM </strong>and Carithers RL, Jr. Clinical features, diagnosis, and screening for primary hepatocellular carcinoma. Up to date in Gastroenterology and Hepatology. Up to date, Inc. Wellesley, MA, Updated 2014.</li>
<li>Curley SA, Stewart KE, <strong>Schwartz JM</strong>, Carthers RL, Jr. Nonsurgical therapies for localized hepatocellular carcinoma. Up to date, Inc. Wellesley, MA, Updated 2014.<strong> </strong></li>
<li><strong>Schwartz JM</strong>. Approach to the patient with a focal liver lesion. Up to date Inc Gastroenterology and Hepatology. Up to date, Inc. Wellesley, MA, Updated 2014.</li>
<li>Hartwell L and <strong>Schwartz JM. </strong>AsymptomaticLiver Chemistry Abnormalities. Journal of Clinical Outcomes Management. 2009; 16 (11): 525-34.</li>
<li>Urquhart J<strong>, Schwartz, JM.</strong> Hepatocellular Carcinoma Surveillance in a Western Population with Hepatitis B. Current Hepatitis Reports, 2011.</li>
<li><strong>Schwartz, JM </strong>and Reinus JF. Prevalence and Natural History of Alcoholic Liver Disease. Clinics in Liver Disease. 2012; 16 (4): 659-66.</li>
</ul>
<p> </p>
David L. Rosenstreich
<p>Dr. David Rosenstreich is Professor of Medicine, <span id="lw_1270136895_0" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial; border-bottom-style: dashed; border-bottom-width: 1px; border-bottom-color: #0066cc; cursor: pointer;">Otolaryngology</span>, and Microbiology and <span id="lw_1270136895_1" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial; border-bottom-style: dashed; border-bottom-width: 1px; border-bottom-color: #0066cc; cursor: pointer; background-image: initial; background-attachment: initial; background-origin: initial; background-clip: initial; background-color: transparent; background-position: initial initial; background-repeat: initial initial;">Immunology;</span> Chief of the Division of Allergy and Immunology; and Director of the Bronx <span id="lw_1270136895_2" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial; border-bottom-style: dashed; border-bottom-width: 1px; border-bottom-color: #0066cc; cursor: pointer;">Asthma </span>Project. His research currently focuses on the effects of inorganic dietary factors on immune reactivity in humans (specifically, the <span id="lw_1270136895_3" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial; cursor: pointer; background-image: initial; background-attachment: initial; background-origin: initial; background-clip: initial; background-color: transparent; border-bottom-style: none; border-bottom-width: initial; border-bottom-color: initial; background-position: initial initial; background-repeat: initial initial;">effects of mercury</span> and acrylamide on human lymphocyte and monocyte production of TH1 and TH2 cytokines in vitro). </p>
<p> </p>
<p>Dr. Rosenstreich completed medical school at <span id="lw_1270136895_4" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial;">NYU School of Medicine</span> and an <span id="lw_1270136895_5" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial;">internal medicine residency</span> at the Bronx Municipal Hospital Center. He spent ten years as an investigator for the National Institutes of Health (NIH), <span id="lw_1270136895_6" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial;">National Institute of Allergy and Infectious Diseases </span>(NIAID) and <span id="lw_1270136895_7" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial; cursor: pointer; background-image: initial; background-attachment: initial; background-origin: initial; background-clip: initial; background-color: transparent; border-bottom-style: none; border-bottom-width: initial; border-bottom-color: initial; background-position: initial initial; background-repeat: initial initial;">National Institute of Dental Research</span> (NIDR), and was a visiting professor at the <span id="lw_1270136895_8" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial; cursor: pointer; background-image: initial; background-attachment: initial; background-origin: initial; background-clip: initial; background-color: transparent; border-bottom-style: none; border-bottom-width: initial; border-bottom-color: initial; background-position: initial initial; background-repeat: initial initial;">Rockefeller University Laboratory</span> of Cellular Physiology and Immunology. He currently serves on the NIAID/NIH <span id="lw_1270136895_9" class="yshortcuts" style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial; cursor: pointer; background-image: initial; background-attachment: initial; background-origin: initial; background-clip: initial; background-color: transparent; border-bottom-style: none; border-bottom-width: initial; border-bottom-color: initial; background-position: initial initial; background-repeat: initial initial;">Data Safety Monitoring Board</span>.</p>
<p> </p>
<p><br style="line-height: 1.2em; outline-style: none; outline-width: initial; outline-color: initial;" />Dr. Rosenstreich has published over 170 articles, invited papers, and reviews, and has edited three books.</p>
<p><strong>(Partial listing from over 170 research articles, invited papers and reviews and 3 edited books)</strong></p>
<ol>
<li>Rosenstreich, D.L., Lehach, J.G. and Armenaka, M.: Successful management of chronic urticaria. Clin. Rev. Allergy, 1992; 10:371-390.</li>
<li>Armenaka, M. and Rosenstreich, D.L.: The pathophysiology of chronic urticaria. Clin. Rev. Allergy, 1992; 10:257-279.</li>
<li>Small, C.B., Kaufman, A., Armenaka, M.C. and Rosenstreich, D.L.: Sinusitis and atopy in human immunodeficiency virus infection. J. Inf. Dis. 167:283-290, 1993. Armenaka, M., Grizzanti, J.N. and Rosenstreich, D.L.: Serum immunoglobulins and IgG subclass levels in adults with chronic sinusitis: evidence for decreased IgG3 levels. Annals Allergy, 72:507-514; 1994.</li>
<li>Youkeles, L.H., Grizzanti, J.N., Liao, Z., Chang, C.J. and Rosenstreich, D.L.: Decreased tobacco glycoprotein-induced lymphocyte proliferation in vitro in pulmonary eosinophilic granuloma. Am. J. Resp. Crit. Care Med., 151:145-150, 1995.</li>
<li>Ellaurie, M., Rubinstein, A. and Rosenstreich, D.L.: IgE levels in pediatric HIV-infection. Annals Allergy, Asthma, Immunology, 75:332-6, 1995.</li>
<li>Rosenstreich, D.L., Eggleston, P.E., Kattan, M. et. al.: Role of cockroaches in the asthma morbidity of inner-city children. New England J. Medicine, 336:1356-1363; 1997.</li>
<li>De Asis, M.B., Rosenstreich, D.L., Chang, C.J., Gourevitch, M.N., and Small, C.B. Effect of prior hepatitis B infection on serum IgE levels in patients with human immunodeficiency virus infection. Ann Asthma and Immunol, 80:35-8; 1998.</li>
<li>Small, C.B., McGowan, J.P., Klein, R.S., Schnipper, S.M., Chang, C.J, and Rosenstreich, D.L. Serum IgE levels in patients with human immunodeficiency virus infection. Ann All Asthma and Immunol, 81:75-80, 1998.</li>
<li>Eggleston, P.A., Rosenstreich, D., Lynn, H., Gergen, P., Baker, D., Kattan, M., Mortimer, L.M., Mitchell, H., Ownby, D., Slavin, R., Malveaux, F. Relationship of indoor allergen exposure to skin test sensitivity in inner city children with asthma. J. Allergy Clin. Immunol., 102: 563-70, 1998.</li>
<li>Gergen, P.J., Mortimer, K.M., Eggleston, P.A., Rosenstreich, D., Mitchell, H., D., Kattan, M., Baker, D., Wright,E.C., Slavin, R., Malveaux, F. Results of the National Cooperative Inner-City Asthma Study (NCICAS) environmental intervention to reduce cockroach allergen exposure in inner-city homes. J. Allergy Clin. Immunol. 103:501-6, 1999</li>
<li>Hudes, G., Vaghjimal, A and Rosenstreich, D.L. Asthma: Diagnosis and Management. in Allergy for Primary Care Physicians, Ed, Altman, Becker and Williams. W.B. Saunders, 2000. </li>
<li>Stevenson, Lori A., P.J. Gergen, D.R. Hoover, D. Rosenstreich, et al Sociodemographic Correlates of Indoor Allergen Sensitivity Among United States Children. J. Allergy Clin. Immunol. 108:747-52, 2001 </li>
<li>Senturia YD. Bauman LJ. Coyle YM. Morgan W. Rosenstreich DL. Roudier MD. Mitchell H. Gruchalla R. Crain EF. The use of parent report to assess the quality of care in primary care visits among children with asthma. Ambulatory Pediatrics. 1:194-200, 2001</li>
<li>Rosenstreich, D.L , Moday, H. and Hudes, G. Asthma and the environment. J. Asthma 40 (Suppl). 23-9, 2003</li>
<li>Hudes, G., Vaghjimal, A and Rosenstreich, D.L. Basic Principles of Allergic Diseases. in Otolaryngology, Basic Science and Clinical Review. Ed. Van de Water and Staeker. Thieme Medical Publishers. 32-43, 2006</li>
<li>Jerschow, El., De Vos, G., Hudes, G., Rubinstein, A., Lipsitz, E., Rosenstreich, D.A Case of Common Variable Immunodeficiency Syndrome Associated With Takayasu Arteritis. Ann All Asthma Immunol. 98:196-9, 2007</li>
<li>de Vos, G. and Rosenstreich, D.L. Immunologic disorders of the larynx. in The Larynx. Ed. M. Fried and A. Ferlito, Plural Publishing. 2007</li>
<li>de Vos, G. S. Abotaga, ZH Liao, E. Jerschow and D. Rosenstreich. Selective effect of mercury on Th2-type cytokine production in humans. Immunopharmacology and Immunotoxicology. 29:537-48, 2007</li>
<li>Jariwala, SP, Fodeman, J., Hudes, G, Ahuja, K, Rosenstreich, D. Functional antibody deficiency in a patient with type I Gaucher disease. J Inherit Metab Dis. 2008 Apr 4. [Epub ahead of print]</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Jariwala%20SP%2522%255BAut… SP</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Moday%20H%2522%255BAuthor%… H</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522de%20Asis%20ML%2522%255BAu… Asis ML</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Fodeman%20J%2522%255BAutho… J</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Hudes%20G%2522%255BAuthor%… G</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522de%20Vos%20G%2522%255BAuth… Vos G</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Rosenstreich%20D%2522%255B… D</a>. The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria. <a>Ann Allergy Asthma Immunol.</a> 102:475-82, 2009</li>
<li><a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Fodeman%20J%2522%255BAutho… J</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Jariwala%20S%2522%255BAuth… S</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Hudes%20G%2522%255BAuthor%… G</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Wittner%20M%2522%255BAutho… M</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Klapper%20P%2522%255BAutho… P</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Liu%20Q%2522%255BAuthor%25… Q</a>, <a href="http://www.ncbi.nlm.nih.gov/pubmed?term=%2522Rosenstreich%20D%2522%255B… D</a>. Scratching the surface. <a>Am J Med.</a> 123:22-6, 2010</li>
</ol>
<p> </p>
<p>David L. Rosenstreich, MD, is Director, Allergy and Immunology and Professor, Medicine at Montefiore Einstein. His clinical focus centers on allergic skin diseases, chronic sinusitis and asthma.</p><p>After obtaining his Bachelor of Science from The City College of New York in 1963, Dr. Rosenstreich earned his Doctor of Medicine from New York University School of Medicine in 1967. He completed his residency in medicine at Einstein in 1969 before becoming a Clinical Associate at the National Institute of Allergy and Infectious Disease, National Institutes of Health until 1971. Dr. Rosenstreich became a Senior Staff Associate until 1972 before moving to the National Institute of Dental Research, National Institutes of Health, where he was Senior Investigator until 1980.</p><p>Building on his clinical focus, Dr. Rosenstreich’s research focuses on the relationship between decreased allergic capacity (immunoglobulin E deficiency) and susceptibility for developing a malignancy. His work has been published in 159 peer-reviewed papers, 64 invited articles and 4 edited books/monographs. Dr. Rosenstreich has been an editor for several scientific journals, such as the <em>Journal of Immunology, Infection</em> and <em>Immunity and Annals of Allergy, Asthma & Immunology</em>.</p><p>Dr. Rosenstreich is board certified by the American Board of Internal Medicine and the American Board of Allergy and Immunology. He is a member of several professional organizations, including the American Association of Physicians, the American Society for Clinical Investigation and the American Academy of Allergy, Asthma and Immunology. Dr. Rosenstreich has won numerous awards for his work, including the Leo M. Davidoff Society for Excellence in Medical Education Award in 2017. He has also been listed in Best Doctors in America, <em>New York Magazine</em> Best Doctors, <em>New York Times</em> Super Doctors, <em>U.S. News & World Report</em> Best Doctors and the Albert Marquis <em>Who’s Who in the World</em> and Lifetime Achievement Award multiple times.</p>
Manish Ramesh
<p>Dr. Manish Ramesh was appointed assistant professor in the Einstein/Montefiore Division of Allergy and Immunology in July 2014. He is director of the Montefiore Medical Center Food Allergy Centers in Scarsdale and the Bronx.</p>
<p>Dr. Ramesh completed fellowship training in Allergy and Immunology at the Icahn School of Medicine at Mount Sinai and residency training in internal medicine at Jacobi Medical Center, where he was best overall resident (PGY3) in 2011. He attended medical school in India at S.C.B. Medical College and subsequently obtained his Ph.D. in immunology from University of Connecticut Health Center.</p>
<p>Dr. Ramesh is board certified in Allergy and Immunology and Internal Medicine.</p>
Garrison Pease
Genitourinary/Urologic (prostate, kidney, bladder, testicle, penis, adrenal gland) Pathology, with focus on one-on-one teaching at the scope with residents and medical students, along with quality assurance and quality improvement mind-set with emphasis on lab efficiency and patient-centered turn-around time.<quillbot-extension-portal></quillbot-extension-portal>
Genitourinary/Urologic Pathology, Quality Assurance and Improvement<quillbot-extension-portal></quillbot-extension-portal>
<p>Garrison Pease, MD, is an attending surgical pathologist and Assistant Professor, Pathology at Montefiore Einstein. His clinical focus centers on genitourinary and urologic pathology, with a focus on one-on-one teaching at the scope with residents and medical students. He is also focused on quality assurance and quality improvement with an emphasis on lab efficiency and patient-centered turn-around time.</p><p>After obtaining his Bachelor of Arts in biology from Saint John's University (Collegeville, MN) in 2009, Dr. Pease earned his Doctor of Medicine at the University of Minnesota in 2013. He completed his anatomic and clinical pathology residency at the University of University of Chicago - NorthShore in 2017, where he was Chief Resident in his final two years. Following this, Dr. Pease completed a general surgical pathology fellowship at Washington University – St. Louis in 2018, followed by a genitourinary pathology fellowship at the University of Washington in 2019.</p><p>Dr. Pease’s research is focused on genitourinary and urologic pathology and quality assurance and improvement. He has worked on the College of American Pathologists (CAP) self and peer-based laboratory inspections. His work has been published in several peer-reviewed journals and shared through abstracts and poster presentations nationally and internationally.</p><p>Dr. Pease is a Diplomate of the American Board of Pathology and is board certified in Anatomic and Clinical Pathology. He is a member of the United States and Canadian Academy of Pathology and the College of American Pathologists. In 2021, Dr. Pease won the Department of Pathology Outstanding Teaching Award from Montefiore Einstein's Pathology Residency program.</p>
Debra H. Pan
<!--Dr. Pan graduated from Soochow University School of Medicine in China, and completed her Pediatric Residency at Long Island College Hospital, and her Pediatric Gastroenterology and Nutrition Fellowship at The Mount Sinai Hospital in New York City. She specializes in viral hepatitis, inflammatory bowel disease, acid reflux, celiac disease, tube feeding, nutrition and endoscopies.--><p>Debra H. Pan, MD, MS, is an Attending Physician in the Division of Gastroenterology, Hepatology, and Nutrition at Children's Hospital at Montefiore (CHAM) and an Associate Professor of Pediatrics at our Albert Einstein College of Medicine. Her clinical focus is on pediatric gastrointestinal and liver conditions such as inflammatory bowel disease, acid reflux, Helicobacter pylori gastritis, tube feeding, endoscopy, cholestasis, viral hepatitis, autoimmune hepatitis, and liver transplant. </p><p>A graduate from Soochow University School of Medicine in China in 1983, Dr. Pan received her Master of Science in Cardiac Electrophysiology from the same institute in 1989. From 1991 to 2000, she completed a postdoctoral research fellowship in Pharmacology and Toxicology at Michigan State University for 2 years and then continued gastrointestinal research at Columbia University. She completed her Pediatric residency at Long Island College Hospital in 2003, and her Pediatric Gastroenterology and Nutrition fellowship at Mount Sinai Hospital in New York City in 2005.</p><p>Dr. Pan's recent research focuses on the treatment outcomes of Helicobacter pylori infection and the natural history of the hepatitis B virus infection. Her work has been published in numerous peer-reviewed journals, books and review articles, and she is also an active journal reviewer for multiple journals.</p><p>Dr. Pan is a member of leading professional societies including North American Society for Pediatric Gastroenterology, Hepatology and Nutrition (NASPGHAN), and the American Association for the Study of Liver Diseases. She is board certified by the American Board of Pediatrics in both General Pediatrics and Pediatric Gastroenterology and Nutrition.</p>